Open access
1,451
Views
0
CrossRef citations to date
0
Altmetric
Research Paper
Synthesis and biological evaluation of C-4 substituted phenoxazine-bearing hydroxamic acids with potent class II histone deacetylase inhibitory activities
Jung-Chun Chua Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei, TaiwanView further author information
, Hui-Ju Tsengb School of Pharmacy, Taipei Medical University, Taipei, Taiwan;c Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, California, United StatesView further author information
, Sung-Bau Leea Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei, TaiwanView further author information
, Kai-Cheng Hsua Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei, Taiwan;d Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan;e Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan;f TMU Research Center for Drug Discovery, Taipei Medical University, Taipei, TaiwanView further author information
, Ling-Wei Hsing School of Pharmacy, College of Medicine, National Taiwan University, Taipei, TaiwanView further author information
, Ru-Hao Liangb School of Pharmacy, Taipei Medical University, Taipei, TaiwanView further author information
, Tony Eight Lind Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan;e Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, TaiwanView further author information
, Nain-Chu Gaoh Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei, TaiwanView further author information
, Liang-Chieh Chenc Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, California, United StatesView further author information
, Wan-Hsun Luh Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei, TaiwanView further author information
, Andrew H.-J Wangi The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, TaiwanView further author information
& Wei-Jan Huanga Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei, Taiwan;b School of Pharmacy, Taipei Medical University, Taipei, Taiwan;h Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei, TaiwanCorrespondence[email protected]
View further author information
show allView further author information
Article: 2212326
|
Received 23 Jan 2023, Accepted 05 May 2023, Published online: 16 May 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.